1. Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
   Jialin Song et al, 2017, Front. Immunol. CrossRef
2. Potential Epigenetic-Based Therapeutic Targets for Glioma
   Lanlan Zang et al, 2018, Front. Mol. Neurosci. CrossRef
3. Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics
   Svetlana Miroshnichenko et al, 2019, Front. Pharmacol. CrossRef
4. null
   E. V. Stupak et al, 2016 CrossRef
5. MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma Cells
   Qing Zhang et al, 2020, Front. Oncol. CrossRef
6. The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression
   Federica Caponnetto et al, 2020, Biomedicines CrossRef
7. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
   Andrea Diana et al, 2020, IJMS CrossRef
8. Role of microRNAs in glioblastoma
   Ming Chen et al, 2021, Oncotarget CrossRef
9. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
   Maria Mortoglou et al, 2021, Arch Toxicol CrossRef
10. Progress in research and development of temozolomide brain-targeted preparations: a review
    Jiefen Yang et al, 2022, Journal of Drug Targeting CrossRef
11. Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy
    Svetlana Gaponova et al, 2022, Cancers CrossRef
12. Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma.
    Akram M Eraky, 2023, Cureus CrossRef